Press Releases

Views & Analysis

Sales & Marketing
shapes pricing and access

How transparent is the VPAS?

The UK’s VPAS – a deal that began on 1st January 2019 and which is due to end on 31st December 2023 – is worth around £7 billion.

Newsletters and Deep Dive
digital magazine

Deep Dive



Sales & Marketing

Vertex's Nicola Massey: the pharmaphorum podcast

In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland. Having joined the biopharmaceutical compan

White Papers


Debates & Insight

Debates & Insight

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan

Partner Content

Sales & Marketing
KOLs Rising stars
Partner Content

Who would your KOLs identify as Rising stars?

To truly discover Rising Stars in a rapidly changing landscape that may no longer recognise traditional metrics – publication numbers, qualifications, involvement in trials, etc – with the